HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 09-FEB-10 3LQL TITLE HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD 594 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AR, ALDEHYDE REDUCTASE, ALDO-KETO REDUCTASE FAMILY 1 MEMBER COMPND 5 B1; COMPND 6 EC: 1.1.1.21; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21GOLD; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS T113A MUTANT, OXIDOREDUCTASE, TIM BARREL, NADP, PHOSPHOPROTEIN, KEYWDS 2 OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.KOCH,A.HEINE,G.KLEBE REVDAT 3 20-MAR-24 3LQL 1 REMARK SEQADV REVDAT 2 24-AUG-11 3LQL 1 JRNL VERSN REVDAT 1 15-DEC-10 3LQL 0 JRNL AUTH C.KOCH,A.HEINE,G.KLEBE JRNL TITL TRACING THE DETAIL: HOW MUTATIONS AFFECT BINDING MODES AND JRNL TITL 2 THERMODYNAMIC SIGNATURES OF CLOSELY RELATED ALDOSE REDUCTASE JRNL TITL 3 INHIBITORS JRNL REF J.MOL.BIOL. V. 406 700 2011 JRNL REFN ISSN 0022-2836 JRNL PMID 21185307 JRNL DOI 10.1016/J.JMB.2010.11.058 REMARK 2 REMARK 2 RESOLUTION. 1.13 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.13 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.102 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.101 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.127 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 5520 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 110261 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.098 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.098 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.123 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 5217 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 103869 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2464 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 476 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3025.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2484.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 22 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 28025 REMARK 3 NUMBER OF RESTRAINTS : 34828 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 ANGLE DISTANCES (A) : 0.136 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.028 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.097 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.159 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.083 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.003 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.040 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.089 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56 REMARK 3 ANISOTROPIC REFINEMENT REDUCED FREE R (NO CUTOFF) BY ? REMARK 4 REMARK 4 3LQL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 22-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1000057606. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91841 REMARK 200 MONOCHROMATOR : SI-111 CRYSTAL REMARK 200 OPTICS : SILICON, RH-COATED REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 110269 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.130 REMARK 200 RESOLUTION RANGE LOW (A) : 8.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04500 REMARK 200 FOR THE DATA SET : 22.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.13 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.11200 REMARK 200 FOR SHELL : 9.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 6000, 120MM AMMONIUM CITRATE, REMARK 280 PH 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.45500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 314 REMARK 465 GLU A 315 REMARK 465 PHE A 316 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 69 CD CE NZ REMARK 470 LYS A 86 CG CD CE NZ REMARK 470 GLU A 127 CD OE1 OE2 REMARK 470 LYS A 222 CG CD CE NZ REMARK 470 ASN A 242 OD1 ND2 REMARK 470 GLU A 280 CG CD OE1 OE2 REMARK 470 HIS A 313 CA C O CB CG ND1 CD2 REMARK 470 HIS A 313 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 1 CG - SD - CE ANGL. DEV. = 16.6 DEGREES REMARK 500 ARG A 4 NE - CZ - NH1 ANGL. DEV. = 5.6 DEGREES REMARK 500 ARG A 4 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 GLU A 61 CG - CD - OE1 ANGL. DEV. = 13.1 DEGREES REMARK 500 TYR A 83 CB - CG - CD1 ANGL. DEV. = 4.8 DEGREES REMARK 500 TYR A 210 CA - CB - CG ANGL. DEV. = 12.9 DEGREES REMARK 500 GLU A 268 CA - CB - CG ANGL. DEV. = 13.2 DEGREES REMARK 500 GLU A 268 CG - CD - OE2 ANGL. DEV. = -12.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 22 -0.28 79.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LDT A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CIT A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A 800 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LQG RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE MUTANT T113A COMPLEXED WITH IDD388 REMARK 900 RELATED ID: 3LBO RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE MUTANT T113C COMPLEXED WITH IDD594 REMARK 900 RELATED ID: 3LD5 RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE MUTANT T113S COMPLEXED WITH IDD594 REMARK 900 RELATED ID: 1US0 RELATED DB: PDB REMARK 900 HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND THE INHIBITOR REMARK 900 IDD594 AT 0.66 ANGSTROM REMARK 900 RELATED ID: 3LEP RELATED DB: PDB REMARK 900 RELATED ID: 3LZ3 RELATED DB: PDB REMARK 900 RELATED ID: 3M4H RELATED DB: PDB REMARK 900 RELATED ID: 3LZ5 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS SEQUENCE CONFLICT HAS BEEN DESCRIBED IN REMARK 999 J BIOL CHEM 1989 SEP 5; 264(25): 14775-7 BY CHUNG S, ET AL., REMARK 999 PUBMED ID 2504709 DBREF 3LQL A 1 316 UNP P15121 ALDR_HUMAN 1 316 SEQADV 3LQL ILE A 5 UNP P15121 LEU 5 SEE REMARK 999 SEQADV 3LQL ALA A 114 UNP P15121 THR 114 ENGINEERED MUTATION SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO ALA GLY PHE LYS SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 A 316 HIS GLU GLU PHE HET NAP A 500 48 HET LDT A 600 24 HET CIT A 700 13 HET BR A 800 1 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM LDT IDD594 HETNAM CIT CITRIC ACID HETNAM BR BROMIDE ION HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN LDT [2-(4-BROMO-2-FLUORO-BENZYLTHIOCARBAMOYL)-5-FLUORO- HETSYN 2 LDT PHENOXY]-ACETIC ACID FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 LDT C16 H12 BR F2 N O3 S FORMUL 4 CIT C6 H8 O7 FORMUL 5 BR BR 1- FORMUL 6 HOH *476(H2 O) HELIX 1 1 PRO A 24 GLY A 39 1 16 HELIX 2 2 ALA A 46 GLN A 50 5 5 HELIX 3 3 ASN A 51 GLU A 65 1 15 HELIX 4 4 LYS A 69 LEU A 73 5 5 HELIX 5 5 TRP A 80 HIS A 84 5 5 HELIX 6 6 LEU A 88 LYS A 101 1 14 HELIX 7 7 ASN A 137 GLU A 151 1 15 HELIX 8 8 ASN A 163 ASN A 172 1 10 HELIX 9 9 GLN A 193 LYS A 203 1 11 HELIX 10 10 ASP A 231 HIS A 241 1 11 HELIX 11 11 THR A 244 GLN A 255 1 12 HELIX 12 12 THR A 266 LYS A 275 1 10 HELIX 13 13 SER A 282 SER A 291 1 10 HELIX 14 14 LEU A 301 THR A 305 5 5 SHEET 1 A 2 ARG A 4 LEU A 6 0 SHEET 2 A 2 LYS A 12 PRO A 14 -1 O MET A 13 N ILE A 5 SHEET 1 B 8 LEU A 18 GLY A 19 0 SHEET 2 B 8 HIS A 42 ASP A 44 1 O ASP A 44 N LEU A 18 SHEET 3 B 8 PHE A 74 LEU A 79 1 O VAL A 76 N ILE A 43 SHEET 4 B 8 LEU A 107 ILE A 110 1 O LEU A 109 N LEU A 79 SHEET 5 B 8 ILE A 157 SER A 160 1 O GLY A 158 N ILE A 110 SHEET 6 B 8 VAL A 182 GLU A 186 1 O VAL A 182 N ILE A 159 SHEET 7 B 8 VAL A 206 TYR A 210 1 O THR A 208 N ILE A 185 SHEET 8 B 8 VAL A 259 VAL A 260 1 O VAL A 259 N ALA A 209 SITE 1 AC1 38 GLY A 19 THR A 20 TRP A 21 LYS A 22 SITE 2 AC1 38 ASP A 44 TYR A 49 LYS A 78 HIS A 111 SITE 3 AC1 38 TRP A 112 SER A 160 ASN A 161 GLN A 184 SITE 4 AC1 38 TYR A 210 SER A 211 PRO A 212 LEU A 213 SITE 5 AC1 38 GLY A 214 SER A 215 PRO A 216 ASP A 217 SITE 6 AC1 38 LEU A 229 ALA A 246 ILE A 261 PRO A 262 SITE 7 AC1 38 LYS A 263 SER A 264 VAL A 265 THR A 266 SITE 8 AC1 38 ARG A 269 GLU A 272 ASN A 273 LDT A 600 SITE 9 AC1 38 HOH A1053 HOH A1061 HOH A1082 HOH A1104 SITE 10 AC1 38 HOH A1109 HOH A1238 SITE 1 AC2 10 TRP A 21 VAL A 48 TYR A 49 HIS A 111 SITE 2 AC2 10 TRP A 112 PHE A 123 ALA A 300 LEU A 301 SITE 3 AC2 10 NAP A 500 BR A 800 SITE 1 AC3 16 GLN A 50 ASN A 51 GLU A 52 ASN A 53 SITE 2 AC3 16 GLU A 54 LYS A 95 ASP A 99 HOH A1016 SITE 3 AC3 16 HOH A1043 HOH A1074 HOH A1183 HOH A1196 SITE 4 AC3 16 HOH A1202 HOH A1216 HOH A1286 HOH A1292 SITE 1 AC4 4 TRP A 112 ALA A 114 PRO A 311 LDT A 600 CRYST1 49.290 66.910 47.360 90.00 92.22 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020290 0.000000 0.000787 0.00000 SCALE2 0.000000 0.014946 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021131 0.00000